Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03177187
Title Combination Study of AZD5069 and Enzalutamide. (ACE)
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom

prostate adenocarcinoma


AZD5069 + Enzalutamide

Age Groups: senior | adult
Covered Countries

No variant requirements are available.